Better control of hyperglycemia after a prolonged duration of insulin use may explain the attenuation of the hazard ratios for insulin use for ≥3 (or ≥5) years for all-cause mortality (mostly ascribed to diabetic vascular complications) and all-noncancer mortality (Table 3). The gene discussed is INS; the disease is Hyperglycemia.